Gadicke Ansbert

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Gadicke Ansbert
CIK #0001134655
EDGAR Form CIK 2011 - 2024
3 [0001134655]
4 [0001134655]
5 [0001134655]
Form 3/4/5 Subject 2011 - 2024
Gadicke Ansbert
TCR2 Therapeutics Inc
Cullinan Therapeutics, Inc.
Allovir, Inc.
MPM BioImpact LLC
iTeos Therapeutics, Inc.
Oncology Impact Fund (Cayman) Management L.P.
UBS Oncology Impact Fund L.P.
Evnin Luke
MPM BioVentures 2014 GP LLC
MPM Asset Management Investors Bv2018 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014, L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2018 B LP
MPM BioVentures 2014 (B), L.P.
Entrada Therapeutics, Inc.
Repare Therapeutics Inc.
MPM Oncology Impact Management GP LLC
Harpoon Therapeutics, Inc.
MPM Oncology Innovations Fund GP LLC
Werewolf Therapeutics, Inc.
MPM Oncology Innovations Fund LP
MPM Asset Management LLC
Foley Todd
Oncorus, Inc.
MPM BioVentures 2018 LLC
Dyne Therapeutics, Inc.
MPM BioVentures 2018 LP
MPM BioVentures 2018 GP LLC
MPM BioVentures V LP
MPM BioVentures V LLC
MPM BioVentures V GP LLC
Rhythm Pharmaceuticals Inc
MPM Asset Management Investors BV5 LLC
Radius Health, Inc.
Chiasma Inc
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV LLC
MPM BioVentures IV QP LP
MPM BioVentures IV Strategic Fund, L.P.
Syndax Pharmaceuticals Inc
MPM BioVentures IV GmbH & Co. Beteiligungs KG
MPM BioVentures IV GP LLC
Scopa James Paul
Kailian Vaughn M
Avalo Therapeutics, Inc.
TriVascular Technologies, Inc.
Aratana Therapeutics Inc
Epizyme, Inc.
Vander Vort John
Histogen Inc.
Pacira BioSciences, Inc.
Wheeler Kurt
Galakatos Nicholas
Steinmetz Michael
Humanigen Inc
Simon Nicholas J III
Somaxon Pharmaceuticals, Inc.
Henner Dennis
Verastem, Inc.
Terms | Privacy | Guide
tony@aum13f.com